| II-49 Janet Wade Population PK analysis of Sym004 and the influence of variations in base model structure on covariate model building Wednesday 15:10-16:30 |
| II-66 Gunnar Yngman Practical considerations for using the full random effects modeling (FREM) approach to covariate modeling Wednesday 15:10-16:30 |
| IV-02 Joćo Abrantes Handling inter-occasion variability in model-based therapeutic drug monitoring Thursday 14:45-16:15 |
| IV-03 Malidi Ahamadi Operating Characteristics of Stepwise Covariate Selection in Pharmacometric Modeling Thursday 14:45-16:15 |
